Gene Expression Profiling of Human Stent-Induced Neointima by cDNA Array Analysis of Microscopic Specimens Retrieved by Helix Cutter Atherectomy
- 13 March 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (10) , 1396-1402
Abstract
Background —Restenosis due to neointima formation is the major limitation of stent-supported balloon angioplasty. Despite abundant animal data, molecular mechanisms of neointima formation have been investigated on only a limited basis in patients. This study sought to establish a method for profiling gene expression in human in-stent neointima and to identify differentially expressed genes that may serve as novel therapeutic targets. Methods and Results —We retrieved tissue specimens from patients with symptomatic in-stent restenosis using a novel helix cutter atherectomy device. cDNA samples prepared from neointima (n=10) and, as a control, from the media of normal arteries (n=14) were amplified using a novel polymerase chain reaction protocol and hybridized to cDNA arrays. Immunohistochemistry characterized the atherectomy material as neointima. cDNA arrays readily identified differentially expressed genes. Some of the differentially expressed genes complied with expected gene expression patterns of neointima, including downregulation of desmin and upregulation of thrombospondin-1, cyclooxygenase-1, and the 70-kDa heat shock protein B. Additionally, we discovered previously unknown gene expression patterns, such as downregulation of mammary-derived growth inhibitor and upregulation of FK506-binding protein 12 (FKBP12). Upregulation of FKBP12 was confirmed at the protein level in neointimal smooth muscle cells. Conclusions —Gene expression patterns of human neointima retrieved by helix-cutter atherectomy can be reliably analyzed by cDNA array technology. This technique can identify therapeutic targets in patients, as exemplified by the findings regarding FKBP12. FKBP12 is the receptor for Rapamycin (sirolimus), which in animal models reduced neointima formation. Our study thus yields a rationale for the use of Rapamycin to prevent restenosis in patients.Keywords
This publication has 10 references indexed in Scilit:
- Balloon Angioplasty Induces Heat Shock Protein 70 in Human Blood VesselsAnnals of Vascular Surgery, 1999
- Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalystsCellular and Molecular Life Sciences, 1999
- Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12Cell, 1999
- Pathophysiology of Restenosis: Interaction of Thrombosis, Hyperplasia, and/or RemodelingThe American Journal of Cardiology, 1998
- Mechanism of TGFβ receptor inhibition by FKBP12The EMBO Journal, 1997
- Intravascular Ultrasound to Discern Device-Specific Effects and Mechanisms of Restenosis**This study was supported in part by the Cardiology Research Foundation and the Medlantic Research Institute, Washington, DC.The American Journal of Cardiology, 1996
- The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I ReceptorsCell, 1996
- Histochemical localization of heart-type fatty-acid binding protein in human and murine tissuesHistochemistry and Cell Biology, 1995
- Transforming growth factor β1‐mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrestJournal of Cellular Physiology, 1993
- Activation of S6 kinase in cultured vascular smooth muscle cells by submitogenic levels of thrombospondinBiochemical and Biophysical Research Communications, 1988